Are AD polygenic risk scores ready for clinical use in risk stratification, or does ancestry-dependent performance limit their applicability?

Polygenic Risk Score Analysis for Late-Onset Alzheimer's Disease

2026-04-16 View full analysis →

0.30

Quality Score

0

Rounds

3

Hypotheses

2

Surviving

120s

Duration

Debate Transcript

No transcript rounds recorded for this debate.